findmyKOL

Rafic Farah, MD

Basic profile

Medical Oncology

ORCIDNone on fileNPI↗
✓ Full record
RegionSeattle, WA · WestSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rafic Farah is an Oncology physician. OpenAlex indexes 53 publications with 784 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
53publications

Distinct works indexed by OpenAlex.

784citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1221 Madison St Fl 10203
Seattle, WA 981043588

Telephone

206-215-2658

Provider last certified this registry record 23 Feb 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 8 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    26.2%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor26.2%
    Acyclovir100%
    Part D≥104 patients

  • Anti-infectives

    19.5%
    Short-acting sulfonamides10.4%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥51 patients
    Azole Antifungal3.9%
    Fluconazole62%Posaconazole38%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    17.2%
    Proton pump inhibitor7.3%
    Pantoprazole Sodium90%Omeprazole10%
    Part D<11 patients
    Corticosteroid4.6%
    Prednisone100%
    Part D≥26 patients

    + 4 more classes in this area

Where care is delivered (Part B)53.5% facility · 46.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 50 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”